HELIUS
LIVE

Serial Number

79285417

Owner

HELIUS THERAPEUTICS LIMITED

Attorney

Sarah P. Harrell

Filing Date

Dec 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HELIUS Trademark

Serial Number: 79285417 • Registration: 6578316

HELIUS is a trademark filed by HELIUS THERAPEUTICS LIMITED on December 18, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HELIUS THERAPEUTICS LIMITED (2 trademarks)

18 Ron Driver Place,

Entity Type: 99

Trademark Details

Filing Date

December 18, 2019

Registration Date

December 7, 2021

Published for Opposition

September 21, 2021

Goods & Services

Pharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

Retail and wholesale store services featuring cannabis medicinal herbs, cannabis oil and derivatives thereof all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; retail and wholesale store services featuring hemp and cannabis cosmetic products and accessories, food products, beverages, personal care preparations, and skin care preparations, all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; providing consumer information featuring the ratings, reviews and recommendations on marijuana and medical marijuana products via a website

Active chemical ingredients for use in the manufacture of pharmaceuticals solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

Cultivation of plants for others featuring solely cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; consultancy services relating to the cultivation of plants; cultivation and breeding for others of cannabis all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; providing health and agricultural information in the field of medical marijuana and cannabis via a website; providing medical information featuring indications and effects of particular cannabis strains, the benefits of medical marijuana, marijuana, cannabis and research related to cannabis and marijuana via a website

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 2, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 23, 2022 FICS
FINAL DISPOSITION PROCESSED
May 23, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 7, 2022 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2021 NREP
REGISTERED-PRINCIPAL REGISTER
Dec 7, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 8, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 20, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 20, 2021 OPNR
NOTIFICATION PROCESSED BY IB
Oct 4, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 21, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 1, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 1, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 1, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 16, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 12, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 12, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 12, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2021 CRFA
ASSIGNED TO LIE
Jul 15, 2021 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 15, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 15, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 15, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 4, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 29, 2021 GNFN
FINAL REFUSAL E-MAILED
Apr 29, 2021 GNFR
FINAL REFUSAL WRITTEN
Apr 29, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2021 TROA
REFUSAL PROCESSED BY IB
Oct 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 30, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 9, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2020 DOCK
ASSIGNED TO EXAMINER
May 25, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 19, 2020 MAFR
ASSIGNED TO EXAMINER
May 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 14, 2020 REPR